Literature DB >> 1910040

Replacement of lysine 234 affects transition state stabilization in the active site of beta-lactamase TEM1.

F Lenfant1, R Labia, J M Masson.   

Abstract

Lysine 234 is a residue highly conserved in all beta-lactamases, except in the carbenicillin-hydrolyzing enzymes, in which it is replaced by an arginine. Informational suppression has been used to create amino acid substitutions at this position in the broad spectrum Escherichia coli beta-lactamase TEM-1, in order to elucidate the role of this residue which lies on the wall at the closed end of the active site cavity. The mutants K234R and K234T were constructed and their kinetic constants measured. Replacement of lysine 234 by arginine yields an enzyme with similar activity toward cephalosporins and most penicillins, except toward the carboxypenicillins for which the presence of the guanidine group enhances the transition state binding. The removal of the basic group in the mutant K234T yields a protein variant which retains a low activity toward penicillins, but losts drastically its ability to hydrolyze cephalosporins. Moreover, these two mutations largely decreased the affinity of the enzyme for penicillins (10-fold for K234R and 50-fold for K234T). This can be correlated with the disruption of the predicted electrostatic binding between the C3 carboxylic group of penicillins and the amine function of the lysine. Therefore, lysine 234 in the E. coli beta-lactamase TEM-1 is involved both in the initial recognition of the substrate and in transition state stabilization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Authors:  C Neuwirth; R Labia; E Siebor; A Pechinot; S Madec; E B Chaibi; A Kazmierczak
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Authors:  C Neuwirth; S Madec; E Siebor; A Pechinot; J M Duez; M Pruneaux; M Fouchereau-Peron; A Kazmierczak; R Labia
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Authors:  Martina Zarnayová; Eliane Siebor; André Péchinot; Jean-Marie Duez; Helena Bujdáková; Roger Labia; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Site-directed mutagenesis of the Actinomadura R39 DD-peptidase.

Authors:  G H Zhao; C Duez; S Lepage; C Forceille; N Rhazi; D Klein; J M Ghuysen; J M Frère
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

5.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Site-directed mutagenesis of proposed active-site residues of penicillin-binding protein 5 from Escherichia coli.

Authors:  M P van der Linden; L de Haan; O Dideberg; W Keck
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

8.  The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.

Authors:  Nuno Mendonça; Vera Manageiro; Frédéric Robin; M José Salgado; Eugénia Ferreira; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

9.  Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics.

Authors:  Wouter Elings; Aleksandra Chikunova; Danny B van Zanten; Ralphe Drenth; Misbha Ud Din Ahmad; Anneloes J Blok; Monika Timmer; Anastassis Perrakis; Marcellus Ubbink
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  The Lactamase Engineering Database: a critical survey of TEM sequences in public databases.

Authors:  Quan Ke Thai; Fabian Bös; Jürgen Pleiss
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.